# TITE-CDP
R script for generating operating characteristics for an isotonic design for phase I cancer clinical trials with late-onset toxicities.

# Reference
Wages NA, Braun TM, Conaway MR. Isotonic design for phase I cancer clinical trials with late-onset toxicities. J Biopharm Stat. 2023; 33(3):357-370. PMID: 36606874
